0001144204-17-011036.txt : 20170224 0001144204-17-011036.hdr.sgml : 20170224 20170224172729 ACCESSION NUMBER: 0001144204-17-011036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170224 FILED AS OF DATE: 20170224 DATE AS OF CHANGE: 20170224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLE ROBERT C CENTRAL INDEX KEY: 0001218007 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13070 FILM NUMBER: 17638704 MAIL ADDRESS: STREET 1: 1248 YELLOW SPRINGS RD CITY: CHESTER SPRINGS STATE: PA ZIP: 19425 4 1 v460293_form4.xml FORM 4 X0306 4 2017-02-24 1 0000892160 DERMA SCIENCES, INC. DSCI 0001218007 COLE ROBERT C 1248 YELLOW SPRINGS RD CHESTER SPRINGS PA 19425 0 1 0 0 See Remarks Common Stock 2017-02-24 4 D 0 69518 D 0 D Stock Option (right to buy) 3.99 2017-02-24 4 D 0 83482 0 D Common Stock 83482 0 D Pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2017, by and among the Issuer, Integra Derma, Inc. and Integra LifeSciences Holdings Corporation (the "Merger Agreement"), as of the Effective Time (as defined in the Merger Agreement), the shares of the Issuer's common stock were converted into the right to receive $7.00 per share to the reporting person in cash. Represents the weighted average exercise price for in-the-money stock options, as described in a Schedule TO and the Issuer's Schedule 14D-9, each as filed with the Securities and Exchange Commission on January 25, 2017, pursuant to which Integra Derma, Inc. offered to purchase all of the Issuer's common stock for $7.00 per share (the "Offer"). In connection with the expiration of the Offer and the subsequent closing of the merger pursuant to the terms of the Merger Agreement, all outstanding stock options became fully vested and exercisable on such date. Each stock option held by the reporting person was then cancelled in exchange for a cash payment representing the difference between the exercise price of such option and $7.00 per share, payable without any interest thereon and subject to any required tax withholdings. The options were originally granted in consideration of the reporting person's services to the Issuer and without payment of consideration. Group President, Traditional Wound Care & Corporate Accounts /s/ Robert C. Cole 2017-02-24